Our results reveal that inhibiting autophagy strengthens the antitumor effects of Nectin-4-MMAE, underscoring the potential of a combined therapeutic approach utilizing Nectin-4-MMAE and autophagy inhibitors for more effective bladder cancer treatment. Here, NECTIN4 is linked to urinary bladder cancer.